According to a blog post, Alto Pharmacy announced a $250 million Series D funding round, bringing its total funding to over $350M. Investors in the round included Softbank plus existing investors including Greenoaks, Jackson Square Ventures, OliveTree Capital, and Zola Global.
Alto’s mission is to fulfill medicines true purpose and improve quality of life for everyone who needs it. As a health-tech startup, we are doing everything we can to fix a broken system and bring world-class care to patients in need. The way we’ve done this is by creating a modern-day pharmacy. We’ve capitalized on what we’ve learned about the way a traditional pharmacy works and built our own in-house pharmacy management system that’s unlike any other.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/Alto%20Pharmacy/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
